Trials / Completed
CompletedNCT03569436
Effectiveness and Safety of Nivolumab in Participants That Have Head and Neck Cancer That Has Come Back or Has Spread
Efficacy and Safety of Nivolumab in Recurrent or Metastatic Head and Neck Cancer (HNC) Patients - Japanese Real-world Data Through Clinical Chart Review
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 262 (actual)
- Sponsor
- Bristol-Myers Squibb · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
Non-interventional study in Japan of participants with HNC recurring or that has spread and who are treated with nivolumab
Conditions
Timeline
- Start date
- 2018-02-14
- Primary completion
- 2020-06-26
- Completion
- 2020-06-26
- First posted
- 2018-06-26
- Last updated
- 2022-02-10
Locations
1 site across 1 country: Japan
Source: ClinicalTrials.gov record NCT03569436. Inclusion in this directory is not an endorsement.